University of Toronto
Researchers from Canada, Sweden and the United States report details of new studies and findings in the area of cardiology
Published in Pharma Investments, Ventures and Law Weekly, June 11th, 2006
Study 1: Aprotinin and tranexamic acid have similar hemostatic effectiveness in high-transfusion-risk cardiac surgery.
According to a study from Canada, "Cardiac surgery with cardiopulmonary bypass may result in excessive fibrinolysis and platelet (PLT) dysfunction, resulting in impaired hemostasis and excessive blood loss. Prophylactic use of the antifibrinolytic drugs aprotinin and tranexamic acid is thought to prevent these hemostatic defects. Their relative clinical utility and safety in high-transfusion-risk cardiac surgery, however, is not known."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Abraxis BioScience, Inc.
Abraxis BioScience posts sales increase of 19% - Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals reports loss of $0.01 per share - Advancis Pharmaceutical Corp.
Advancis Pharmaceutical posts net loss of $0.25 per share - Adventrx Pharmaceuticals, Inc.
Adventrx closes merger with SD Pharmaceuticals - Akorn, Inc.
Akorn reports first quarter 2006 revenues of almost $30 million - Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals posts loss per share of $0.88 - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
